Posted 17th January 2020 by Joshua Sewell
Despite recent advances in the gene therapy field, significant challenges lie ahead for the consistent manufacturing and release of these medicines. Analytical methods and automation need to keep pace as more medicines move towards the market and more quality control resources are required. Well-developed methods on robust platforms will be crucial to ensure the quality of these novel medicines for the doctors and patients who need them.
Posted 16th December 2019 by Liv Sewell
Ahead of the 3rd Global Bioprocessing, Bioanalytics and ATMP Manufacturing Congress in Dublin, we consider how Ireland is uniquely positioned to play a significant role in the next generation of biopharmaceutical manufacturing and delivery of life changing medicines.
Posted 8th July 2019 by Joshua Sewell
Following the Global Bioprocessing, Bioanalytics and ATMP Manufacturing Congress, we have made the following presentation slides from Jonathan Cartoux, Denis Decubber, Hani El-Sabbahy, Julia Leach & Corne Stroop.
Posted 3rd April 2019 by Joshua Sewell
Ireland is a place where innovation thrives and foreign direct investment finds a home. Thirty years ago, just 5,200 worked in an industry characterised by basic manufacturing. Now, the originator pharmaceutical companies directly employ 30,000 people, working on complex biologics manufacturing and the discovery of tomorrow’s cures.
Posted 8th February 2019 by Joshua Sewell
You have probably already heard of diversity and inclusion, but isn’t this just another management term? No, not this time! I hope I can convince you that there is real magic in inclusion and embracing diversity. I will introduce you to the world of diversity and inclusion, what it looks like in your daily work routine, and how it can help you and your team. I will also provide you with a few tools and ideas on how to improve inclusion within your team.
Posted 25th May 2018 by Jane Williams
Process intensification and continuous biomanufacturing continue to attract a lot of interest within the biopharmaceutical industry as a method that can increase productivity and make the most efficient use of production assets.
Posted 9th May 2018 by Jane Williams
Bioprocesses are traditionally performed in (fed-) batch processes for the production of various recombinant proteins and therapeutics. Batch processing comprises of processes where the material flow has hold steps in between two unit operations where the product is recovered from each unit operation step. However, such batch processes are attributed to longer process time and costs, and inconsistent process performance.